You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Oesophageal cancer

Pembrolizumab with chemoradiotherapy for untreated unresectable oesophageal cancer [ID6270]

  • Awaiting development
  • Reference number: GID-TA11303
  • Expected publication date: TBC
  • Project information
  • Project documents

Documents

Documents created during the development process.

Notes

  • Note

  • Note

  • Timelines for this appraisal will be available in due course

Back to top